Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.

作者: Xiaonan Qiu , Haixia Zhu , Sang Liu , Guoquan Tao , Jing Jin

DOI: 10.1111/JGH.13533

关键词:

摘要: Background and Aim In our previous study, we demonstrated that four microRNAs (miRNAs) (miR-26a, miR-142-3p, miR-148a, miR-195) were downregulated in both plasma tumor tissues confirmed to be promising non-invasive diagnostic biomarkers for gastric cancer (GC). Methods We used the quantitative reverse transcription polymerase chain reaction assess expression levels of miRNAs from paraffin-embedded surgical specimens GC patients. Kaplan–Meier curves log-rank test applied predict correlation between cumulative overall survival (OS) patients with GC. Besides, performed vitro assays including cell proliferation, migration, invasion colony formation, apoptosis. Results The median miRNA as cutoff value classify into high or low groups. Down-regulation miR-26a miR-148a was significantly associated shorter OS either set (miR-26a: P = 0.009; miR-148a: P = 0.005) validation P = 0.011; P = 0.024). When two sets combined, Cox regression analysis independent prognostic factors predicting HR = 0.76, 95% CI = 0.61–0.94; HR = 0.73, CI = 0.58–0.91). Furthermore, elevated miR-26 suppressed induced apoptosis MGC-803 cells compared negative control groups (P < 0.05). Conclusion These findings supported could serve potential

参考文章(29)
Qing-Zhong Yuan, Xi-Xue Zhao, Guo-Zheng Pan, Dong-Po Mu, Peng-Peng Ding, Qing-Ao Bo, Fa-Ping You, Ming-Xin Wang, Guo-Qiang Li, Di-Wen Sun, Long Hao, Tao Cui, Jian Zhang, MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer. International Journal of Clinical and Experimental Pathology. ,vol. 8, pp. 368- 373 ,(2015)
Feng-Hua Liu, Gang Chen, Jiang-Hua Wu, Yong Tang, Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer. International Journal of Clinical and Experimental Medicine. ,vol. 7, pp. 5947- 5957 ,(2014)
Nicola Amodio, Marco Rossi, Lavinia Raimondi, Maria Rita Pitari, Cirino Botta, Pierosandro Tagliaferri, Pierfrancesco Tassone, miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies Oncotarget. ,vol. 6, pp. 12837- 12861 ,(2015) , 10.18632/ONCOTARGET.3805
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
Mi Jeong Heo, Young Mi Kim, Ja Hyun Koo, Yoon Mee Yang, Jihyun An, Sook-Kyung Lee, Seung Jin Lee, Kang Mo Kim, Joong-Won Park, Sang Geon Kim, microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Oncotarget. ,vol. 5, pp. 2792- 2806 ,(2014) , 10.18632/ONCOTARGET.1920
Michele Dal Bo, Riccardo Bomben, Luis Hernández, Valter Gattei, The MYC/ miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential Oncotarget. ,vol. 6, pp. 19381- 19392 ,(2015) , 10.18632/ONCOTARGET.4574
QI-CHUN SONG, ZHI-BIN SHI, YONG-TAO ZHANG, LE JI, KUN-ZHENG WANG, DA-PENG DUAN, XIAO-QIAN DANG, Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients Oncology Reports. ,vol. 31, pp. 1263- 1270 ,(2014) , 10.3892/OR.2014.2989
Manuela Ferracin, Angelo Veronese, Massimo Negrini, Micromarkers: miRNAs in cancer diagnosis and prognosis Expert Review of Molecular Diagnostics. ,vol. 10, pp. 297- 308 ,(2010) , 10.1586/ERM.10.11